Healthcare Solutions Mgmt. Group Inc. (HSMD)

[sunspotter]

"Can there be a clinical trial setup for a liquid, "ingredient free" medicine, and somewhere in the middle of the trial, just switch to "ingredient free" tablets?"

No.

The company concerned would need to do a series of bridging studies that demonstrated to the Regulatory Agency's satisfaction that the two different formulations are bioequivalent, and if a straightforward bioequivalence study can't be done

- and for "wave-based information composites", I can envisage some minor technical challenges (LOL)-

then a full therapeutic equivalence study would have to be conducted, or possibly two.

And I have a feeling that might be problematic, because in the real universe that you and I inhabit, neither product has any efficacy whatsoever.